AT510867A5 - Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon - Google Patents

Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon Download PDF

Info

Publication number
AT510867A5
AT510867A5 ATA9089/2010A AT90892010A AT510867A5 AT 510867 A5 AT510867 A5 AT 510867A5 AT 90892010 A AT90892010 A AT 90892010A AT 510867 A5 AT510867 A5 AT 510867A5
Authority
AT
Austria
Prior art keywords
dimethoxy
hydroxystilene
melange
inhibition
cosmetic compositions
Prior art date
Application number
ATA9089/2010A
Other languages
English (en)
Other versions
AT510867A2 (de
Original Assignee
Sami Labs Ltd
Majeed Muhammed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Labs Ltd, Majeed Muhammed filed Critical Sami Labs Ltd
Publication of AT510867A2 publication Critical patent/AT510867A2/de
Publication of AT510867A5 publication Critical patent/AT510867A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Offenbart ist das kosmezeutische Potential von 3,5-Dimethoxy-4'-hydroxystilben im Hinblick auf dessen Melanogenese-hemmenden und fotoprotektiven Aktivitäten. Ebenfalls offenbart ist eine topische Melanogenese-hemmende Zusammensetzung, umfassend 0,01 bis 50 Gew.-% 3,5-Dimethoxy-4'-hydroxystilben.
ATA9089/2010A 2009-03-23 2010-05-21 Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon AT510867A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/408,808 US20100240767A1 (en) 2009-03-23 2009-03-23 Melanogenesis inhibitiuon by 3,5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
PCT/US2010/035766 WO2010111719A2 (en) 2009-03-23 2010-05-21 Melanogenesis inhibition by 3, 5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof

Publications (2)

Publication Number Publication Date
AT510867A2 AT510867A2 (de) 2012-07-15
AT510867A5 true AT510867A5 (de) 2012-12-15

Family

ID=42738197

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9089/2010A AT510867A5 (de) 2009-03-23 2010-05-21 Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon

Country Status (4)

Country Link
US (1) US20100240767A1 (de)
AT (1) AT510867A5 (de)
GB (1) GB2481170A (de)
WO (1) WO2010111719A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322159A1 (de) * 2009-10-30 2011-05-18 Green Molecular, S.L. Verwendung von Pterostilben (PTER) als Medikament zur Vorbeugung und/oder Behandlung von Hauterkrankungen, -schädigungen oder Verletzungen oder als Kosmetikmittel
US8841350B2 (en) 2011-05-11 2014-09-23 ChromaDex Inc. Method for inducing UDP-glucuronosyltransferase activity using pterostilbene
CN103393579B (zh) * 2013-08-08 2014-10-22 珀莱雅化妆品股份有限公司 一种美白修复脂质纳米粒乳液的制备方法
WO2016014529A1 (en) * 2014-07-21 2016-01-28 Wisys Technology Foundation, Inc. Skin lightening compounds
US9980924B2 (en) * 2014-09-04 2018-05-29 The Regents Of The University Of California Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin
WO2018034327A1 (ja) * 2016-08-17 2018-02-22 香港友池有限公司 プテロスチルベン配糖体を含む内用組成物
CN106755133B (zh) * 2017-01-20 2021-05-25 深圳大学 一种酶法制备邻苯酚类化合物的方法
JP6807894B2 (ja) * 2017-08-31 2021-01-06 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤
CN109419634B (zh) * 2017-08-31 2023-01-31 富士胶片株式会社 水包油型乳化组合物以及皮肤外用剂

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175854A (ja) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk 津液改善用皮膚外用剤
WO1999059561A2 (en) * 1998-05-18 1999-11-25 Hensley, Kenneth, L. Resveratrol inhibition of myeloperoxidase
WO2003039557A1 (en) * 2001-11-02 2003-05-15 The Regents Of The University Of California Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
US20030118617A1 (en) * 2001-12-21 2003-06-26 Avon Products, Inc. Resveratrol analogues
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
WO2008157787A2 (en) * 2007-06-20 2008-12-24 Kent State University Hydroxylated tolans and related compounds in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10175854A (ja) * 1996-10-18 1998-06-30 Dokutaazu Kosumeteikusu:Kk 津液改善用皮膚外用剤
WO1999059561A2 (en) * 1998-05-18 1999-11-25 Hensley, Kenneth, L. Resveratrol inhibition of myeloperoxidase
WO2003039557A1 (en) * 2001-11-02 2003-05-15 The Regents Of The University Of California Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection
US20030118617A1 (en) * 2001-12-21 2003-06-26 Avon Products, Inc. Resveratrol analogues
WO2003103583A2 (en) * 2002-06-10 2003-12-18 Oklahoma Medical Research Foundation A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system
WO2008157787A2 (en) * 2007-06-20 2008-12-24 Kent State University Hydroxylated tolans and related compounds in the treatment of cancer

Also Published As

Publication number Publication date
WO2010111719A3 (en) 2010-11-18
US20100240767A1 (en) 2010-09-23
GB2481170A (en) 2011-12-14
WO2010111719A2 (en) 2010-09-30
AT510867A2 (de) 2012-07-15
GB201117769D0 (en) 2011-11-30

Similar Documents

Publication Publication Date Title
AT510867A5 (de) Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon
WO2010010295A3 (fr) Composition cosmetique coloree de longue tenue
WO2012035029A3 (en) Cosmetic composition comprising a dyestuff, said dyestuff and cosmetic treatment process
BR112012007685A2 (pt) uso de derivados de banzotropolona, produto de cuidado com o corpo, agente de limpeza e tratamento doméstico, compostos, e , uso dos compostos
BRPI0508098A (pt) compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
WO2013122932A4 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
BRPI0821235A2 (pt) Composição de moldagem termoplástica, usos de composto e de composição de moldagem termoplástica, e, fibra, folha, ou uma moldagem.
EP4299077A3 (de) Hautverstärkende zusammensetzungen und verfahren
MX2011012366A (es) Mezclas fungicidas sinergeticas.
WO2009135006A3 (en) Methods for preventing oxidative damage to hair and promote hair shine
WO2012084701A3 (en) Cosmetic composition comprising a cucurbic acid compound and a hydrophobic inulin
WO2008037380A3 (de) Alkylbenzoat gemische
HK1215579A1 (zh) 被取代的2，3-二氫苯並呋喃基化合物和其用途
WO2012019934A3 (en) Anti-dandruff compositions with citrus fibres
WO2008121315A3 (en) Compositions and methods for inhibiting melanogenesis
GB0812006D0 (en) Organic compounds
BRPI0815455B8 (pt) compostos derivados de n-fenilacetamida, composição farmacêutica, composição cosmética, uso cosmético de uma composição, e usos de um composto do mesmo
DE502005008631D1 (de) Dermatologischen zubereitungen
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
FR2973226B1 (fr) Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse
UA104994C2 (uk) Придатна для розпилення композиція, що містить екстракт із листя червоного винограду
WO2012136818A3 (en) Cosmetic composition comprising a cucurbic acid compound and a blend of acrylic polymers
BR112015001006A2 (pt) composições farmacêuticas contendo ácido lático oligomérico
TW201129358A (en) Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation
ATE477797T1 (de) Zusammensetzung enthaltend magnolol und honokiol in synergistischen mengen

Legal Events

Date Code Title Description
REJ Rejection

Effective date: 20160515